Higher SERCA2 immunolabelling was detected in tubulovillous (50%) more than tubular adenomas (38.5%) and in CRAs with HGD more than those with LGD (64.3 and 26.7% respectively). The gene discussed is ATP2A2; the disease is tubular adenoma.